PMID- 11129441 OWN - NLM STAT- MEDLINE DCOM- 20010222 LR - 20191104 IS - 1052-9551 (Print) IS - 1052-9551 (Linking) VI - 9 IP - 4 DP - 2000 Dec TI - ETV6/CBFA2 fusions in childhood B-cell precursor acute lymphoblastic leukemia with myeloid markers. PG - 184-9 AB - A translocation resulting in a fusion of ETV6 (TEL) gene at 12p13 and CBFA2 (AML1) gene at 21q22 is variably reported in 16-36% of cases of childhood acute lymphoblastic leukemia (ALL). This t(12;21)(p13;q22) is not detectable by conventional cytogenetic methods and was reported to be associated with B-cell precursor ALL with presumed favorable prognosis. We have examined 18 cases of well characterized childhood B-cell precursor ALL with cytogenetic, immunophenotypic, and clinical data for the presence of the t(12;21) using fluorescence in situ hybridization (FISH). Fourteen of the 18 cases (78%) were positive for fusion ETV6/CBFA2. One of seven adult ALL patients was positive (12% of cells positive in this 21 year old patient). By contrast, no evidence of t(12;21) by FISH was noted in two childhood T-ALL cases and 10 normal bone marrow samples. Twelve of the 14 positive childhood cases had CD13 and/or CD33 expression (myeloid markers) while only one of the four negative cases was CD13 and CD33 positive. Eight of 12 cases positive for t(12;21), and with conventional cytogenetic data, had structural and/or numerical chromosome abnormalities other than the detected t(12;21). One case had relapse with gradual increase in percentage of cells positive for t(12;21) and development of an isochromosome 21 carrying the fusion signals. The data reveal a strong association of t(12;21) with B-cell precursor ALL, especially with myeloid marker expression. FAU - Rafi, S K AU - Rafi SK AD - Genetics Department, Yale University School of Medicine, New Haven, Connecticut 06520-8005, USA. FAU - El Gebaly, H AU - El Gebaly H FAU - Qumsiyeh, M B AU - Qumsiyeh MB LA - eng PT - Journal Article PL - United States TA - Diagn Mol Pathol JT - Diagnostic molecular pathology : the American journal of surgical pathology, part B JID - 9204924 RN - 0 (Biomarkers, Tumor) RN - 0 (Core Binding Factor Alpha 2 Subunit) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (TEL-AML1 fusion protein) SB - IM MH - Adolescent MH - Adult MH - Biomarkers, Tumor/*genetics MH - Burkitt Lymphoma/diagnosis/*genetics/pathology MH - Child MH - Child, Preschool MH - Core Binding Factor Alpha 2 Subunit MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Infant MH - Male MH - Myeloid Progenitor Cells/chemistry/*pathology MH - Oncogene Proteins, Fusion/*genetics MH - Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/*genetics/pathology MH - *Translocation, Genetic EDAT- 2000/12/29 11:00 MHDA- 2001/03/03 10:01 CRDT- 2000/12/29 11:00 PHST- 2000/12/29 11:00 [pubmed] PHST- 2001/03/03 10:01 [medline] PHST- 2000/12/29 11:00 [entrez] AID - 10.1097/00019606-200012000-00002 [doi] PST - ppublish SO - Diagn Mol Pathol. 2000 Dec;9(4):184-9. doi: 10.1097/00019606-200012000-00002.